What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones ...

Natera, Inc. (NASDAQ:NTRA) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 12, ...

Genetic testing company Natera (NASDAQ:NTRA). will be reporting results this Thursday afternoon. Here’s what investors should know. Natera beat analysts’ revenue expectations last quarter, reporting ...

A Relative Strength Rating upgrade for Natera shows improving technical performance. Will it continue?

A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, and Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced that the two companies have ...

Natera has recently launched Zenith genomics, a next-generation whole genome sequencing assay developed with MyOme to improve ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present new data at the 2025 International Association for the Study of Lung Cancer ...

“We delivered outstanding results in the second quarter, with record Signatera growth and continued strength across our women’s health and organ health product lines,” said Steve Chapman, chief ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication in npj Precision Oncology of the validation study for its Latitude tissue-free ...